Difference between revisions of "Team:Technion Israel"
Line 58: | Line 58: | ||
<nav> | <nav> | ||
<div class="main1"> | <div class="main1"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Project">Project</a> |
<span class="btn-bg1"></span> | <span class="btn-bg1"></span> | ||
<div class="sub1"> | <div class="sub1"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Overview">Overview</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Bacillus">Bacillus</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Project/E_Coli">E.Coli</a> |
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/NADPH">NADPH</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Comb">Comb</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Modeling">Modeling</a> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 71: | Line 74: | ||
<div class="sub2"> | <div class="sub2"> | ||
<a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a> | <a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Protocols">Protocols</a> |
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="main3"> | <div class="main3"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria">Judging Criteria</a> |
<span class="btn-bg3"></span> | <span class="btn-bg3"></span> | ||
<div class="sub3"> | <div class="sub3"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Parts">Parts</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria/Achievements">Achievements</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Collaborations">Collaborations</a> |
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Design">Design</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Entrepreneurship">Entrepreneurship</a> | ||
</div> | </div> | ||
</div> | </div> | ||
<div class="main4"> | <div class="main4"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices">Human Practices</a> |
<span class="btn-bg4"></span> | <span class="btn-bg4"></span> | ||
<div class="sub4"> | <div class="sub4"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Education">Education</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Publications">Publications</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Market_Research">Market Research</a> |
</div> | </div> | ||
</div> | </div> | ||
<div class="main5"> | <div class="main5"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Team">Team</a> |
<span class="btn-bg5"></span> | <span class="btn-bg5"></span> | ||
<div class="sub5"> | <div class="sub5"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Team/About_Us">About Us</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Attributions">Attributions</a> |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Team/Sponsors">Sponsors</a> |
</div> | </div> | ||
</div> | </div> |
Revision as of 09:42, 16 August 2015
Hello! Welcome to our temporary wiki page!
Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.
Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!